Answers are grounded in this paper and cite their sources.
Background: Urolithiasis is a very common urinary tract disorder all over the world. It involves urinary tract calculus formation in urolithiasis. Although the surgical and pharmacological treatments have improved, the recurrence is still high, and current treatment options have associated side effects. Phytochemicals like flavonoids, alkaloids, phenolics, tannins, and saponins found in medicinal plants have exhibited very promising antioxidant, nephroprotective, and anti-urolithic properties. Sarcocephalus cadamba (syn. Neolamarckia cadamba) and Kalanchoe pinnata are used traditionally in different Indigenous systems of medicine for the treatment of renal disease and inflammation, respectively. However, their therapeutic potential as a polyherbal formulation has not been thoroughly explored. Objective: The present study was designed to assess the pharmacological, antioxidant, and anti-urolithic activities of the poly herbal formulation, prepared from poly herbal extract of Sarcocephalus cadamba and Kalanchoe pinnata in an ethylene glycol-induced urolithic disease experimental animal model. Materials and Methods: The leaves of Sarcocephalus cadamba and Kalanchoe pinnata were identified, dried, powdered, and extracted by the Soxhlet extraction method. The extracts were mixed in an optimized ratio and optimized to make a polyherbal preparation. Phytochemical screening, total phenols, total flavonoid content, and in vitro antioxidant activity (DPPH and FRAP) were performed. Oral toxicity studies conducted in accordance with OECDGuidelines for the Testing ofChemicals were performed acutely. The anti-urolithic activity was tested in Wistar albino rats in an ethylene glycol-induced calcium oxalate nephrolithiasis model. Biochemical changes in urine, serum renal biomarkers, serum antioxidant enzymes (SOD, CAT, GSH, and MDA), kidney weight, crystal deposition, and histopathological changes were measured. One-way ANOVA followed by Tukey's post hoc test was used to perform statistical analysis, and a p-value of < 0.05 was considered statistically significant. Results: The results revealed the presence of bioactive phytoconstituents (flavonoids, phenolics, tannins, alkaloids, and saponins) and have high antioxidant activity in the polyherbal formulation. Compared to the disease control group, treatment led to a significant decrease in urinary Ca, oxalate, phosphate, and uric acid concentration and urinary volume, and increased urinary citrate excretion, showing that treatment had beneficial effects on 24hour urine calcium, oxalate, phosphate, uric acid, and volume, with serum creatinine being increased. Endogenous antioxidant enzymes were restored, and oxidative stress was significantly lowered. The histopathological findings in this study showed reduced calcium oxalate crystal deposition, tubular degeneration, and preserved normal renal architecture. The anti-urolithic therapeutic effects of the polyherbal formulation were similar to those of the standard anti-urolithic drug. Conclusion: The antioxidant, nephroprotective, and anti-urolithic activities of Sarcocephalus cadamba and Kalanchoe pinnata polyherbal formulation on experimental animals were found to be significant. These pharmacological properties observed may also be caused by the interaction of several phytoconstituents, lowering the calcium oxalate crystallization, calcium mobilization, oxidative stress, and maintaining renal function. The traditional remedy of both of these plants was scientifically validated in this review regarding their safe, effective, and economical herbal medicine for the prevention and management of urolithiasis. Further clinical studies are warranted to clarify, in humans, their effectiveness and safety.
No takes yet. Share an insight, caveat, or question.
Ubnare et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: